Page 32 - Indian Markets

Govt, RBI, Sebi watching markets closely: FM Nirmala Sitharaman

FM said they are taking necessary measures to ensure orderly functioning of the stock markets and maintain macro-financial stability

Zomato's slim ad-spend sets marketing benchmark for firms seeking to list

Despite the frugal ad spends, Zomato's IPO managed to generate bids worth Rs 2.1 trillion

Sebi revising risk management framework for mutual funds: Official

Capital markets regulator Sebi is in the process of issuing a revised risk management framework for mutual fund industry in view of the changes in the industry landscape which will define the roles

Indices rebound as stimulus, earnings help offset coronavirus fears

Analysts said though markets are concerned about the delta variant the availability of more vaccines is reassuring

Glenmark Life Sciences to invest Rs 600 cr to double capacity in four years

Glenmark Life Sciences is the arm of drug major Glenmark Pharmaceuticals.

Risk-return profiles can vary a lot among balanced advantage funds

Before investing, check the fund's returns during market crash

Adani Group stocks fall for second day on Sebi probe over compliance

Shares of all six listed Adani group companies slipped in early trading Tuesday

Tatva Chintan Pharma IPO is second-most subscribed this year at 180 times

Is second only to MTAR Tech; Tatva's 3.26-million share offering garnered bids for 588 million shares, generating demand worth Rs 63,713 crore

Sebi extends regulatory compliance timeline for debenture trustees

In addition, Sebi has extended the time period till October 31, 2021, for submitting the net worth certificate of guarantor

Mutual fund industry's AUM pegged to touch Rs 92 trillion by 2030

Gross household investments in MFs have grown at a compound annual growth rate (CAGR) of 27.3 per cent over FY13-20

Investors should stick to algo strategy even if it underperforms: Analysts

Hang in there for the optimal period to enjoy the kind of gains seen in back-testing

Tatva Chintan IPO subscribed 15 times on second day of subscription

The price range for the offer has been fixed at Rs 1,073-1,083 per share.

Boom in digital dabba trading

Much like illegal dabba trading, the platform itself is the counterparty to trades by the customer

Markets priced to perfection; don't factor in third Covid wave: Jigar Shah

The markets are priced to perfection and do not take into account a third wave., says Shah

Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription

The initial public offer aggregating up to Rs 500 crore comprises a fresh issue of up to Rs 225 crore and an offer for sale of up to Rs 275 crore.

Tech stocks power Sensex, Nifty shares to record highs; Wipro rises 2.5%

Infosys closed 0.3 per cent higher after posting strong earnings and raising its forecast on the back of a pandemic-driven expansion in digital offerings by businesses globally.

Rupee snaps 3-day winning streak, drops 10 paise to 74.59 against dollar

Halting its three-day winning run, the rupee on Wednesday declined by 10 paise to close at 74.59 (provisional) against the US dollar. At the interbank foreign exchange market, the domestic currency opened at 74.57 against the American currency, and slipped further to close at 74.59, registering a decline of 10 paise over its previous close. On Tuesday, the rupee had closed at 74.49 against the US dollar. Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, fell 0.05 per cent to 92.70. "The market focus is on how Jerome Powell will react to the surging US CPI data and how long can Federal Reserve policy stay ultra-loose. Powell's dovish tone at tonight's semi-annual testimony, will be negative for USDINR spot but if he talks about tapering the bond purchases then we may see the spot to trade towards 75 zone," said Rahul Gupta, Head Of Research- Currency, Emkay Global Financial Services. As long as the spot trades above 74.40, the tre

M-cap of BSE-listed firms touches record high, crosses Rs 233 trn

The market capitalisation of BSE-listed companies reached an all-time high of Rs 2,33,06,440.17 crore on Wednesday, mainly driven by optimistic sentiments in the broader market. At close of trade, the BSE Sensex jumped 134.32 points or 0.25 per cent to 52,904.05, registering its second straight session of gains. The market capitalisation of BSE-listed companies reached the new record high of Rs 2,33,06,440.17 crore at the end of the day's trade. Investors' wealth has jumped Rs 1,42,806.24 crore in the two days of market rally. "Despite negative global signals, domestic indices trimmed its early losses and soared high supported by robust Q1FY22 result expectations on IT sector and favourable economic outcomes," Vinod Nair, Head of Research at Geojit Financial Services, said. IT companies Tech Mahindra, HCL Tech and Infosys were the biggest gainers among the 30-share pack followed by L&T, Tata Steel, ITC and TCS. On the other hand, Maruti, HUL, Dr Reddy's, Nestle India and Titan ..

Sensex witnesses best session in six weeks; ICICI Bank gains 2.83%

This was the best single-day gains for the index since May 31.

Indian equities are attractive, mainly on fundamentals: Ashmore's Jan Dehn

A large part of the market buoyancy over the past few months in India has been on account of mid- and small-caps, says Dean